Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006 Aug;54(8):2550-57.
Update on the treatment of lupus nephritis. Kidney Int. 2006 Aug 23.
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA. 2006 Jul 26;296(4):397-402.
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int. 2006 Jul 5.
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis. 2006 Jul;65(7):913-918.
Effects of Sleep Deprivation on the development of autoimmune disease in an experimental model of Systemic Lupus Erythematosus. Am J Physiol Regul Integr Comp Physiol. 2006 Jun 29.
Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus. Arthritis Rheum. 2006 Jun 26;54(7):2211-2219
A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. J Biochem Mol Biol. 2006 May 31;39(3):229-39.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant. 2006 May;6(5 Pt 1):859-66.
The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the definition of improvement. Arthritis Rheum. 2006 May 31;55(3):355-363.
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther. 2006 May 5;8(3):R83.
B cell targeted therapies in autoimmune diseases. J Rheumatol Suppl. 2006 May;77:24-8.
Mycophenylate mofetil: what role in the treatment of lupus? Lupus. 2006;15(3):179-82.
More on Researching Lupus
Congressional Appropriations Report Calls For Wider Range of Lupus Research at the National Institutes of Health
Road to lupus therapy evinces plight of development
« Back to the Clinical Trial ResultsMain page
Lupus Research Institute 330 Seventh Avenue, Suite 1701, New York, NY 10001 T: 212.812.9881 F: 212.545.1843 e-mail: Lupus@LupusNY.org
Contact Webmaster